| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CLINDERMATOL.2003.08.015 |
| P698 | PubMed publication ID | 14678719 |
| P2093 | author name string | Alan Menter | |
| Alice B Gottlieb | |||
| Frank C Victor | |||
| P433 | issue | 5 | |
| P304 | page(s) | 392-397 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Clinics in Dermatology | Q5133863 |
| P1476 | title | Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis | |
| P478 | volume | 21 |
| Q37762734 | A case of concurrent vitiligo and psoriasis |
| Q33530087 | A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis |
| Q45965393 | Analysis of the levels of tumour necrosis factor (TNF), autoantibodies to TNF, and soluble TNF receptors in patients with rheumatoid arthritis. |
| Q24187673 | Anti-TNF agents for paediatric psoriasis |
| Q24201907 | Anti-TNF agents for paediatric psoriasis |
| Q37810960 | Anti-TNF-α Agents in the Treatment of Immune-Mediated Inflammatory Diseases: Mechanisms of Action and Pitfalls |
| Q36094366 | Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin |
| Q24235424 | Biologics for chronic plaque psoriasis |
| Q38582187 | Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha |
| Q36699918 | Dendritic cells and cytokines in human inflammatory and autoimmune diseases |
| Q37945301 | Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? |
| Q54285327 | Does MBL2 codon 54 polymorphism play a role in the pathogenesis of psoriasis? |
| Q37290478 | Drug focus: adalimumab in the treatment of moderate to severe psoriasis |
| Q59154938 | Effective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions |
| Q30984470 | Emerging drugs for moderate-to-severe psoriasis |
| Q39570426 | Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q36541961 | Infliximab for the treatment of psoriasis |
| Q42472143 | Influence of infliximab on keratinocyte apoptosis in psoriasis patients. |
| Q35109173 | Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin |
| Q38799600 | New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis |
| Q24676343 | Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation |
| Q46138558 | Psoriasis and lasting implications |
| Q39276466 | SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. |
| Q38611360 | Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy. |
| Q46731189 | Serious infections among a large cohort of subjects with systemically treated psoriasis |
| Q48106607 | Synthesis and evaluation of a tag-free photoactive phospho-ceramide analogue-1 (PCERA-1) probe to study immunomodulation in macrophages. |
| Q60919608 | The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms |
| Q36277428 | The role of T cells in cutaneous autoimmune disease |
| Q43138001 | Topical isoflavonoids reduce experimental cutaneous inflammation in mice |
| Q46975812 | Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy |
| Q84324579 | [A new view of psoriasis] |
Search more.